Tseng, Hsin-Yi <br/><br/>
Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma.  [electronic resource] 

 -  International journal of cancer  10 2020 
 - 2176-2189 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.33000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins--metabolism<br/>Cell Death--drug effects<br/>Cell Line, Tumor<br/>Down-Regulation--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Synergism<br/>Humans<br/>Male<br/>Melanoma--drug therapy<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Myeloid Cell Leukemia Sequence 1 Protein--metabolism<br/>Proteins--metabolism<br/>Pyrimidines--pharmacology<br/>Thiophenes--pharmacology<br/>Up-Regulation--drug effects